Key Points Johnson & Johnson (NYSE: JNJ) just rewarded its shareholders again with a quarterly dividend. As a Dividend King, ...

Johnson & Johnson (NYSE:JNJ) shares traded in the green on Monday, snapping six consecutive days of losses. The stock closed ...

Johnson & Johnson closed $19.62 below its 52-week high ($168.85), which the company achieved on September 4th.

New job will include analysts, engineers, microbiologists, scientists, specialists, managers and senior leaders ...

Market analysts liked the news, with analysts for Cantor writing that this was a “best-case data update.” ...

Johnson & Johnson’s high EBIT Margin [TTM] of 26.40% is not only an indicator of the company’s financial health, but also demonstrates its positioning within the Pharmaceuticals Industry.

As a result, Icontinue to cover Johnson & Johnson with a 'Buy' rating. Equally important, the New Brunswick, New Jersey-based company, led by its CEO Joaquin Duato, was able to make significant ...

Johnson & Johnson must adapt and evolve our businesses in the midst of a complex and rapidly changing external environment,” a company spokesperson said in an emailed statement. The company ...

Johnson & Johnson has increased its dividend for more than 60 consecutive years. And thanks to $19 billion in annual free ...